Qiaamp dna ffpe kit
The QIAamp DNA FFPE Kit is a laboratory equipment designed for the purification of DNA from formalin-fixed, paraffin-embedded (FFPE) tissue samples. The kit utilizes a silica-based membrane technology to efficiently extract and isolate DNA from FFPE samples, which can be used for various downstream applications.
Lab products found in correlation
84 protocols using qiaamp dna ffpe kit
Whole-Genome Sequencing of Tumor and Endometriosis Samples
Robust DNA Extraction from FFPE Samples
Methylation Profiling of FFPE Glioma Samples
Methylation analysis and normalization was performed as previously described [21 (link)]. Briefly, methylation data were processed with the statistical software R (version 3.6.1) using the Minfi [22 (link)] and ChAMP [22 (link)–24 (link)] packages. IDH mutational status was acquired using a published DNA methylation-based classifier [9 (link)]. 1p19q codeletion status was acquired through copy number variations inferred from the array. Correlation between the T2-FLAIR mismatch sign and DNA-methylation profiles was evaluated by unsupervised hierarchical clustering of the 5000 most variable CpG sites including only patients with IDH-mut non-codel gliomas (N = 29).
LOH Detection in FFPE Tumor Samples
DNA Extraction and NGS Library Preparation
DNA was extracted using a QIAamp DNA FFPE Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The quantification of genomic DNA samples was assessed with a Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific, Inc., Wilmington, DE, USA).
DNA was stored at − 20 °C for future use. At least 500 ng of DNA was required to perform the NGS library preparation. The library was prepared by using KAPA Biosystems library preparation reagents. The library had an average fragment size of 140–200 bp. Hybrid capture was performed by using NimbleGen Capture reagents.
Nucleic Acid Extraction from FFPE, FNA, and Fresh Tissue
CRC Tumor Sampling and DNA Extraction
DNA Purification from FFPE Samples
Comprehensive EGFR Mutation Analysis
Targeted ERBB Mutation Profiling in HER2+ Breast Cancer
Germany) as per manufacturer’s protocol and quantified using QuBit. We designed
an Agena MassARRAY panel to assay for 67 novel ERBB gene family
somatic mutations in 227 HER2+ breast cancer patients (
mass spectrometry-based genotyping (Agena MassARRAY, San Diego, CA, USA), which
was applied as previously described.14 (link) Reactions where >15% of the resultant mass ran in the mutant site were
scored as positive.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!